NasdaqGS:BRKRLife Sciences
Bruker Bets On Diagnostics And NMR To Reinforce Growth Story
Bruker (NasdaqGS:BRKR) announced new products in microbiology, infection diagnostics and NMR technology, alongside the European launch of a fully automated molecular diagnostics system.
The company is expanding its MALDI Biotyper and MyGenius PRO platforms and progressing the integration of Molzym and its pathogen diagnostics portfolio.
For investors tracking Bruker, the news arrives with the shares at $39.67. The stock shows mixed performance, with a 13.8% return over the past 30 days and...